Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges about its schedule for an upcoming investor meeting. On Friday, May 23, 2025, the company will participate in the Mirae Asset Conference in an in-person format with an investor group. The company has clarified that the schedule is tentative and may change due to unforeseen circumstances. Importantly, the company stated that only publicly available information will be discussed during the interaction, and no unpublished price sensitive information (UPSI) will be shared. The intimation has been made in compliance with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine compliance filing with no new business or financial information, so it is unlikely to have a direct impact on the stock price. Investors may monitor the meeting for any management commentary on growth strategy or business outlook.